Dechert Advises MedinCell on IPO

PARIS – Dechert LLP advised MedinCell on its IPO on the regulated market of Euronext in Paris. MedinCell is a technology-based pharmaceutical company developing a portfolio of long-acting injectable products in different therapeutic areas.

As part of its initial public offering, MedinCell has completed a capital increase of €30 million, which may be increased to €32.5 million if the over-allotment option is fully exercised. These funds will enable MedinCell to expand and accelerate the development of its product portfolio and technology platform. MedinCell will reach a market capitalization of approximately €144 million on the day of its introduction.

The Dechert team advising MedinCell on the legal aspects of the IPO was composed of:

• on corporate and capital markets law aspects: François Hellot, partner, with Quentin Durand, senior associate, Benhouda Derradji and Léa Simovic, associates ;
• on US law aspects: Patrick Lyons, partner with Amy Rees, associate ;
• on tax law aspects: Sabina Comis, partner, with Pierre-Emmanuel Floc’h, associate ; 
• on intellectual property aspects: Marie Fillon, national partner ; 
• on regulatory law aspects: Sophie Pelé, national partner, with Jessica Garestier, associate ; 
• on labor law aspects: Thibault Meiers, senior associate. 

The banking syndicate, Bryan, Garnier & Co Ltd. and Crédit Agricole Corporate and Investment Bank acted as Global Coordinators, Lead Partners and Associated Bookkeepers. The syndicate was advised by Jones Day with Florent Bouyer, lead partner, Florent Le Prado, Aurélien Gredy and Patricia Jimeno on corporate and capital markets aspects, Linda Hesse, partner, and Vanida Narraiden on US law aspects , Philippe Marchiset on IP aspects and Emmanuel de Rochethulon, partner, and Stéphane Raison on tax aspects.

Allegra Finance (Yannick Petit, Evelyne Galiatsatos) advised MedinCell on financial aspects.

Read the French press release »

About Dechert
Dechert is a leading global law firm with 27 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.